# TransMedics Group, Inc. (TMDX) FY2026 YTD Q2 P&L / Income Statement

- Company: TransMedics Group, Inc. (TMDX)
- Period: 2026-01-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-04, accession number 0001193125-26-332843
- Page: https://plicit.ai/financials/tmdx/fy2026-ytd-q2-income-statement
- Chart image: https://plicit.ai/charts/tmdx-fy2026-ytd-q2-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2026-01-01 through 2026-06-30. View: Product and service. Revenue and costs use their disclosed categories.

- **Total revenue**: 363,881,000 US dollars
- **Total cost of revenue**: 149,522,000 US dollars
- **Gross profit**: 214,359,000 US dollars
- **Total operating expenses**: 177,326,000 US dollars
- **Income from operations**: 37,033,000 US dollars
- **Total other expense, net**: negative 9,143,000 US dollars
- **Income before income taxes**: 27,890,000 US dollars
- **Provision for income taxes**: 5,893,000 US dollars
- **Net income**: 21,997,000 US dollars
- **Net product revenue revenue**: 219,130,000 US dollars
- **Service Revenue revenue**: 144,751,000 US dollars
- **Net product revenue cost of revenue**: 49,874,000 US dollars
- **Service Revenue cost of revenue**: 99,648,000 US dollars
- **Research, development and clinical trials**: 56,511,000 US dollars
- **Selling, general and administrative**: 120,815,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Business Segment by Geography

- Page: https://plicit.ai/financials/tmdx/fy2026-ytd-q2-income-statement/revenue-by-business-segment-by-geography
- Chart image: https://plicit.ai/charts/tmdx-fy2026-ytd-q2-revenue-by-business-segment-by-geography-sankey.png

Income statement for 2026-01-01 through 2026-06-30. View: Segments by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenue**: 363,881,000 US dollars
- **Total cost of revenue**: 149,522,000 US dollars
- **Gross profit**: 214,359,000 US dollars
- **Total operating expenses**: 177,326,000 US dollars
- **Income from operations**: 37,033,000 US dollars
- **Total other expense, net**: negative 9,143,000 US dollars
- **Income before income taxes**: 27,890,000 US dollars
- **Provision for income taxes**: 5,893,000 US dollars
- **Net income**: 21,997,000 US dollars
- **OCS transplant revenue - UNITED STATES**: 350,647,000 US dollars
- **OCS transplant revenue - All Other Countries**: 10,889,000 US dollars
- **Undisclosed (calculated)**: 2,345,000 US dollars
- **Research, development and clinical trials**: 56,511,000 US dollars
- **Selling, general and administrative**: 120,815,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.